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We present a case of Tricuspid valve Aspergillus endocarditis with saddle shaped massive
pulmonary embolism occurring in an immunocompetent host. The patient was managed
uniquely by pulmonary endarterectomy (PEA) and combination antifungal chemotherapy
with Liposomal amphotericin-B þ caspofungin.
Copyright © 2014, Cardiological Society of India. All rights reserved.1. Introduction
Fungal endocarditis is uncommon and accounts for less than
10% of all cases of infective endocarditis. Fungal endocarditis
is related usually to intravenous drug abuse, cardiac pros-
thesis or an immunocompromised state. Aspergillus species
causes approximately 20e30% of all fungal endocarditis cases
while rests of the cases are contributed usually by Candida
species.1 Here we present the case of complicated right sided
Aspergillus endocarditis in an immune host that was
encouragingly managed by synergistic antifungal drugs and
PEA.(G. Jain).
ociety of India. All rights2. Case report
A 23-year-old female was referred for cardiac evaluation in
view of moderate to high grade fever since past 1 month and
worsening dyspnea from New York heart association (NYHA)
class II to NYHA class IV over the past 15 days. The patient's
temperature was 101 F and blood pressure was 100/48 mm
Hg. Her heart rate and respiratory ratewere 110 beats/min and
28/min respectively. On physical examination the patient had
pallor and a prominent VeY descent waveform in Jugular
venous pulse. No clubbing, or peripheral stigmata of endo-
carditis were present on physical examination. The restingreserved.
i n d i a n h e a r t j o u r n a l 6 6 ( 2 0 1 4 ) 5 3 9e5 4 2540oxygen saturation on room air was 85%. The patient denied
any history suggestive of congenital heart disease in child-
hood; steroid abuse and intravenous (i.v.) drug abuse. Her
hemoglobin was low (9.0 g/dL), white blood cell count was
normal (10,400/mm3) but demonstrated a left shift (72% neu-
trophils and 14% bands) and platelet count was 105,000/mm3.
Other biochemical investigationswerewithin normal limits. A
transthoracic echocardiography (TTE) revealed:
1. Dilated right atrium, right ventricle, and large
(~2.5  2.0 cm) mobile vegetation attached to the septal
leaflet of the tricuspid valve causing severe regurgitation
(Fig 1A).
2. A restrictive perimembranous ventricular septal defect
(VSD) (<1/3rd of the size of aortic annulus) with tricuspid
valve vegetation impinging on it.
3. Large thrombus adherent to the pulmonary valve,
extending in to the main pulmonary artery (MPA) and its
bifurcation causing severe pulmonary stenosis of
100mmHg gradient with streaky antegrade flow (Fig. 1B, C,
D). The right ventricle and conus were free from the
vegetation. The left sided structures were normal.
After obtaining multiple blood samples for cultures, the
patient was started on empiric vancomycin and amikacin.
Patient then underwent spiral chest computed tomography
with contrast enhancement that showed filling defects inMPA
and its bifurcation by a saddle shaped thrombus (Fig 2A). An
alveolar opacity was noted in the lower left lung parenchyma
suggestive of consolidation with syn-pneumonic effusion.
The patient was then shifted for emergency surgery.3. Surgical and postoperative course
1. Upon Oblique right atriotomy, multiple friable vegetations
were found on tricuspid valve, with thickening and
destruction of leaflet tissue (Fig. 2B). Tricuspid valvulec-
tomy with annular debridement was done. Right ven-
triculotomy with outflow tract incision extending
transannularly into MPA was given. After pulmonary val-
vulectomy and annular debridement, thrombus cast
adherent to the MPA and branch pulmonary artery was
removed with endarterctomy by creating a dissection
plane between intima and the media (Fig. 2C, D). VSD was
closed with pericardial patch. Pulmonary and tricuspid
valves were replaced by Carpentier-Edwards porcine bio-
prosthetic valve with 27 mm and 33 mm diameter respec-
tively. Excised specimen pathology revealed mononuclear
infiltrate with tissue invasion by branching fungi having
septate hyphae consistent with filamentous Aspergillus
species. Culture of the infected tissue showed the growth
of Aspergillus fumigatus. Antibiotic was then changed to
Liposomal Amphotericin-B (3 mg/kg/day). However the
patient continued to have fever in the postoperative
course, so a week later caspofungin (70 mg on day 1 fol-
lowed by 50 mg daily thereafter as i.v. infusion) was added
for the next 4 weeks. The patient subsequently became
afebrile, discharged and now continues to demonstrate
good functional capacity, normal cell counts and nodisease recurrence in her clinical and echo follow up since
past one year.4. Discussion
The optimal treatment approach for fungal endocarditis re-
quires aggressive surgical debridement in conjunction with
antifungal therapy. Our patient presentation, echocardio-
graphic findings and subsequent management were unique
on the following grounds:
1. Congenital heart disease is a substrate for infective endo-
carditis in 10e20% of young adults. The absence of neu-
tropenia; steroid abuse; intravenous drug abuse; lymphoid
or leukemic disease led us to the presumption of normal
immune status of the patient with VSD being the only
predisposing defect. A recently published case report also
describes A. fumigatus endocarditis in an immunocompe-
tent patient.2 The resting desaturation on presentation can
be explained by near systemic right sided pressure with
bidirectional shunting across VSD or ventilation-perfusion
mismatch arising out of lung infection.
2. Severe pulmonary stenosis arising out of a fungal
thrombus adherent to MPA and proximal branches was a
unique finding. A case report describes similar scenario
when the Melody percutaneous valve implanted for pul-
monary homograft constriction got occluded by a massive
pulmonary fungal thrombus of Aspergillus origin that was
removed by embolectomy.3 TEE was not done because as a
cost effective approach, we do TEE in only those patients
who have poor echo window, prosthetic valves or a nega-
tive TTE with a high index of clinical suspicion.
3. As the fungal thrombus was adherent to the intima of
pulmonary vasculature so it was decided to perform PEA
which is a well-established procedure in the treatment of
chronic thromboembolic pulmonary hypertension
rather. There is a single report of PEA in infectious pul-
monary embolism thus making our surgical manage-
ment unique.4 While this report does not recommend
PEA due to inability to find a cleavage plane, we were able
to dissect into the intimal layer. With endarterectomy we
were able to remove the vegetation enbloc while an
attempt at piecemeal removal would have resulted in
embolisation or incomplete debridement. As the vege-
tation cast also extended into the bifurcation we could
not resort to the technique of pulmonary root replace-
ment that is described for isolated pulmonary valve
endocarditis.5
4. Voriconazole is approved for first-line therapy in Invasive
aspergillosis.6 Not only because of availability in our set up,
we used the combination of liposomal amphotericin B and
caspofungin with the rationale of achieving synergism by
inhibition of fungal cell wall biosynthesis by caspofungin
and loss of fungal cellmembrane integrity by amphotericin
B. A recent prospective study also showed promising re-
sults with such combination in invasive aspergillosis
compared with monotherapy in immunocompromised
patients.7
Fig. 2 e (A) Pre operative 3D-CT angiogram showing filling defects in MPA and its bifurcation (arrow). (B) Following
atriotomy, friable, bulky vegetation attached to the tricuspid valve (arrow). (C) RVOT incision extended into MPA showing
embolus in MPA (arrow). (D) Y-shaped fungal cast removed after pulmonary endarterectomy.
Fig. 1 e (A) Apical 4 chamber view showing large mobile vegetation on septal leaflet of tricuspid valve. RA ¼ right atrium;
RV ¼ right ventricle. (B) Suprasternal view showing fungal mass almost completely filling the main pulmonary artery. (C)
Parasternal short axis view showing saddle shaped fungal mass in pulmonary artery. RVOT ¼ right ventricular outflow
tract; Ao ¼ aortic rim. (D) Severe pulmonary stenosis of ~ 100 mm Hg across the pulmonary valve.
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An immunocompetent host, aggressive surgical debridement
and combination antifungal therapy for invasive aspergillosis
resulted in favorable prognosis in our patient. Large vegeta-
tion can embolise to the pulmonary vasculature creating se-
vere pulmonary stenosis that requires emergency removal by
embolectomy or endarterectomy.Conflicts of interest
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